ALX ONCOLOGY HOLDINGS INC Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five
ALX ONCOLOGY HOLDINGS INC (ALXO) had Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five of $163.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive · last filed 2025-03-06
- 2024-12-31: Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five $163.00K.
- 2024-09-30: Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five $1.13M.
- 2024-06-30: Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five $1.13M.
- 2024-03-31: Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five $1.13M.
| Period end | Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five |
|---|---|
| 2024-12-31 | $163.00K 10-K · filed 2025-03-06 |
| 2024-09-30 | $1.13M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.13M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.13M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.13M 10-K · filed 2024-03-07 |
| 2023-09-30 | $2.07M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.07M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.07M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.07M 10-K · filed 2023-03-09 |
| 2022-09-30 | $3.00M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.00M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $2.15M 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |